SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008775
Filing Date
2022-05-13
Accepted
2022-05-13 16:53:39
Documents
72
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krbp-20220331x10q.htm   iXBRL 10-Q 1389494
2 EX-31.1 krbp-20220331xex31d1.htm EX-31.1 23209
3 EX-31.2 krbp-20220331xex31d2.htm EX-31.2 19813
4 EX-32.1 krbp-20220331xex32d1.htm EX-32.1 7883
5 EX-32.2 krbp-20220331xex32d2.htm EX-32.2 8004
  Complete submission text file 0001558370-22-008775.txt   6528104

Data Files

Seq Description Document Type Size
6 EX-101.SCH krbp-20220331.xsd EX-101.SCH 43381
7 EX-101.CAL krbp-20220331_cal.xml EX-101.CAL 46507
8 EX-101.DEF krbp-20220331_def.xml EX-101.DEF 194197
9 EX-101.LAB krbp-20220331_lab.xml EX-101.LAB 431225
10 EX-101.PRE krbp-20220331_pre.xml EX-101.PRE 341001
66 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20220331x10q_htm.xml XML 1152147
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39619 | Film No.: 22923655
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences